Description

GLOW Blend 70 mg — Triple Peptide Combination for Skin, Recovery & Tissue Research

The GLOW Blend combines three complementary research peptides — GHK-Cu (copper tripeptide), BPC-157 (body protection compound), and TB-500 (thymosin beta-4 fragment) — in a single vial. This combination has been studied for its overlapping effects on skin remodeling, collagen synthesis, tissue repair, angiogenesis, and cellular regeneration, making it a popular research tool for investigating multi-pathway recovery and aesthetic-related endpoints.

What It Is

• Class: Combined peptide blend — copper-binding tripeptide + cytoprotective pentadecapeptide + actin-sequestering peptide fragment
• Concept: Three peptides addressing complementary pathways: GHK-Cu drives copper-mediated skin remodeling and antioxidant signaling, BPC-157 supports cytoprotection and angiogenesis, and TB-500 promotes cell migration and tissue regeneration.
• Format: Research-grade synthetic peptide blend supplied as a lyophilized powder.

Proposed Mechanisms (Preclinical)

Skin & Collagen Pathways (GHK-Cu)

• Binds copper ions (Cu²⁺) to form a bioactive complex influencing tissue remodeling.
• Supports collagen and elastin synthesis in dermal fibroblast research.
• Engages antioxidant and anti-inflammatory signaling in skin and connective tissue models.

Cytoprotection & Vascular Effects (BPC-157)

• Promotes VEGF expression and neovascularization at injury sites.
• Supports fibroblast activity and collagen deposition during tissue remodeling.
• Research into mucosal and connective-tissue cytoprotection.

Cellular Migration & Repair (TB-500)

• Acts on the actin cytoskeleton, supporting cellular migration to sites of injury.
• Investigations into endothelial cell proliferation and capillary formation.
• Studies on accelerated wound closure and tissue regeneration.

Selected Research Highlights

• Skin Remodeling Studies: GHK-Cu has been investigated for effects on skin elasticity, wrinkle depth, and dermal density in research models.
• Wound Healing Research: Combined-peptide approaches examining accelerated closure of dermal and connective-tissue wounds in animal models.
• Tendon & Soft Tissue Repair: BPC-157 and TB-500 have been studied for combined effects on tendon, ligament, and muscle injury models.
• Antioxidant Investigations: Research on GHK-Cu’s role in modulating oxidative stress markers and supporting cellular detoxification pathways.

Chemical & Handling Information

• Type: Combined synthetic peptide blend
• Components: GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex), BPC-157 (15-amino-acid gastric-derived peptide), TB-500 (synthetic fragment of thymosin beta-4) — exact ratios per lot specification
• Appearance: Lyophilized powder with a faint blue tint from the copper-bound GHK-Cu component
• Solubility: Reconstitutes readily in bacteriostatic water or sterile saline for laboratory preparation

Specifications

• Peptide Blend: GHK-Cu + BPC-157 + TB-500
• Amount: 70 mg total per vial
• Form: Lyophilized powder
• Purity: ≥99% (HPLC); COA per lot available
• Packaging: Sealed glass vials with rubber stopper and aluminum crimp seal, suitable for standard laboratory handling

Storage & Stability

• Store lyophilized vials in a cool, dry place, protected from light.
• Refrigeration or freezing of the lyophilized peptide is recommended for extended stability, in accordance with standard laboratory SOPs.
• After reconstitution, store at 2–8 °C for short-term laboratory use (typically up to 30 days).
• For long-term storage of reconstituted material, aliquot and freeze at −20 °C or below.
• Avoid repeated freeze-thaw cycles, which can degrade peptide integrity.

Research Use Disclaimer

This product is sold strictly for laboratory research use only. Not intended for human or animal consumption. Not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition. Customers are solely responsible for the lawful handling, storage, and use of this product in accordance with all applicable laws and regulations.